These Cannabis ETFs Fall Short Amidst S&P/TSX Discontinuation: What Investors Need To Know
Portfolio Pulse from Joana Scopel
Cannabis ETFs are under scrutiny due to their performance and lack of diversification. Alan Brochstein, founder of New Cannabis Ventures and 420 Investor, criticizes AdvisorShares Pure US Cannabis ETF (MSOS) and Amplify Seymour Cannabis ETF (CNBS) for their high concentration in a few stocks. He also points out the challenges faced by ETFMG Alternative Harvest ETF (MJ). The discontinuation of two cannabis-related indices due to declining investor interest and losses in the sector further emphasizes the struggles within the cannabis industry.
August 28, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amplify Seymour Cannabis ETF (CNBS) is criticized for its high concentration in a few stocks, despite having a less concentrated portfolio compared to MSOS.
The criticism of CNBS's high concentration in a few stocks could lead to investor concern, negatively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
ETFMG Alternative Harvest ETF (MJ) faces challenges due to its selection of securities and high concentration in its own fund, MJUS.
The criticism of MJ's selection of securities and high concentration in its own fund could lead to investor concern, negatively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
AdvisorShares Pure US Cannabis ETF (MSOS) is criticized for its lack of diversification and high concentration in a few stocks, which could lead to potential sell-offs.
The criticism of MSOS's lack of diversification and high concentration in a few stocks could lead to investor concern and potential sell-offs, negatively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100